(1)          Maegdefrau U, Bosserhoff AK: BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells. Exp Mol Pathol 92: 74-81 (2012)

(2)          Spangler B, Kappelmann M, Schittek B, Meierjohann S, Vardimon L, Bosserhoff AK*, Kuphal S: ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer 130: 2801-2811 (2012) *: corresponding autor

(3)          Riechers A, Bosserhoff AK: Pitfalls in immunohistochemistry - a recent example. Int J Clin Exp Pathol 5: 137-139 (2012)

(4)          Sinnberg T, Sauer B, Holm P, Spangler B, Kuphal S, Bosserhoff AK, Schittek B: MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop. Exp Dermatol 21: 265-270 (2012)

(5)          Junglas B, Kuespert S, Seleem AA, Struller T, Bösl M, Bosserhoff A, Köstler J, Wagner R, Tamm ER, Fuchshofer R: Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork. Am J Pathol 180: 2386-2403 (2012)

(6)          Eckey M, Kuphal S, Straub T, Rümmele P, Kremmer E, Bosserhoff AK, Becker PB: Nucleosome remodeler SNF2L suppresses cell proliferation and migration and attenuates Wnt signalling. Mol Cell Biol 32: 2359-2371 (2012)

(7)          Meyer S, Fuchs TJ, Bosserhoff AK, Hofstädter F, Pauer A, Roth V, Buhmann JM, Moll I,  Anagnostou N, Brandner J, Ikenberg K, Moch H, Landthaler M, Vogt T, Wild P: A SevenMarker Signature and Clinical Outcome in Malignant Melanoma: A LargeScale TissueMicroarray Study With Two Independent Patient Cohorts. PLoS One 7: e38222 (2012)

(8)          Schmidt J, Riechers A, Raphael Stoll R, Amann T, Fink F, Spruss T, Gronwald W, König B, Hellerbrand C, Bosserhoff AK: Targeting Melanoma Metastasis and Immunosuppression with a new Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition. PLoS One 7: e37941 (2012)

(9)          Schubert TE, Bosserhoff AK, Peyssonaux C, Echtenacher B, Knutson M, Hofstädter F, Männel DN: Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis. Mol Med Report 6: 838-842 (2012)

(10)        Schiffner S, Chen S, Becker JC, Bosserhoff AK: Highly pigmented Tg(Grm1) mouse melanoma develops non-pigmented melanoma cells in distant metastases. Exp Dermatol 21: 768-788 (2012)

(11)        Schubert T, Denk AE, Ruedel A, Kaufmann S, Hustert E, Bastone P, Bosserhoff AK: Fragments of SLIT3 inhibit cellular migration. Int J Mol Med 30:1133-1137 (2012)

(12)        Valletta D, Czech B, Müller-Schilling M, Bosserhoff AK, Hellerbrand C: Expression and function of the atypical cadherin FAT1 in chronic liver disease. Biochem Biophys Res Commun 426: 404-408 (2012)

(13)        Ellmann L, Joshi M, Resink T, Bosserhoff A, Kuphal S: BRN-2 is a transcriptional repressor of CDH-13 (T-cadherin) in melanoma cells. Lab Invest 92: 1788-1800 (2012)

(14)        Fischer S, Bayersdorfer F, Harant E, Reng R, Arndt S, Bosserhoff AK, Schneuwly S: fussel (fuss) – a novel negative regulator of BMP signaling in Drosophila melanogaster. PLoS One 7: e42349 (2012)

(15)        Blau L, Knirsh R, Ben-Dror I, Kuphal S, Hau P, Proescholdt M, Bosserhoff AK, Vardimon L: Aberrant expression of the proto-oncogene c-Jun in glioblastoma: IRESmediated translational activation. PNAS 109: E2875-2884 (2012)

(16)        Bauer K, Gosau M, Bosserhoff A, Reichert T, Bauer R: P-cadherin controls the differentiation of oral keratinocytes by regulating cytokeratin 1/10 expression via C/EBP-beta-mediated signaling. Differentiation 84: 345-354 (2012)

(17)        Yang PT, Anastas JN, Toroni RA, Shinohara MM, Goodson JM, Bosserhoff AK, Chien AJ, Moon RT: WLS inhibits melanoma cell proliferation through the β-catenin signaling pathway and induces spontaneous metastasis. EMBO Mol Med 4: 1294-1307 (2012)